Aesiva is the first to standardise the taxonomy of aesthetic procedures, products and brands in Australia — so demand-side treatment data and supply-side product data finally speak the same language.
What was performed, where on the body. “Upper Face Anti-Wrinkle”, regardless of brand used.
Maps every procedure to every product class that can legitimately deliver it — one standard, applied across every clinic on the panel.
What delivered it, down to brand. “Botulinum Toxin Type A”: Botox, Dysport, Nuceiva, Xeomin.
Map your treatment menu once. Keep your practice management software, your workflow and your patients exactly as they are.
Treatment share, geographic penetration and outcome data, built to the standard your compliance team expects.
Live benchmarks unlock when your clinic joins the panel.
Request accessSyndicated reporting is available to briefed partners.
Request a briefingSee how your pricing and revenue per patient sit against anonymised benchmarks for your channel, state and local area.
Spot which treatment categories are accelerating — and which are cooling — before your patients start asking for them.
Understand which treatments and combinations drive the most value in clinics like yours, and build your menu around them.
Track rebooking, patient value and treatment mix over time against the market, not just against last month.
Treatment-level market share by brand, geography and clinic channel — measured from real clinic activity, not estimates.
Identify under-penetrated regions, channels and treatment categories where your next point of share is cheapest to win.
Watch new product uptake against incumbents week by week, by state and clinic type, from the first month in market.
Give sales and territory teams a live, territory-level read of category demand to plan calls and defend share.